Incidence of hospital admissions due to adverse drug reactions in france: the emir study

Benard-Laribiere, Anne; Miremont-Salame, Ghada; Perault-Pochat, Marie-Christine; Noize, Pernelle; Haramburu, Françoise

Type de document :

Article dans une revue scientifique: Article original

DOI :

10.1111/fcp.12088

PMID :

24990220

URL permanente :

http://hdl.handle.net/20.500.12210/15940

Titre :

Incidence of hospital admissions due to adverse drug reactions in france: the emir study

Auteur(s) :

Benard-Laribiere, Anne [Auteur]
Miremont-Salame, Ghada [Auteur]
Perault-Pochat, Marie-Christine [Auteur]
Noize, Pernelle [Auteur]
Haramburu, Françoise [Auteur]

Titre de la revue :

Fundamental & clinical pharmacology

Nom court de la revue :

Fundam Clin Pharmacol

Numéro :

Pagination :

106-11

Date de publication :

2015-02-01

ISSN :

1472-8206

Mot(s)-clé(s) en anglais :

adverse drug reactions
pharmacovigilance
prospective studies
incidence
hospitalization

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

To assess the incidence of hospital admissions related to adverse drug reactions (ADRs) in France and the frequency of preventable ADRs in France, a prospective study was conducted among a representative randomly selected ...
Lire la suite >To assess the incidence of hospital admissions related to adverse drug reactions (ADRs) in France and the frequency of preventable ADRs in France, a prospective study was conducted among a representative randomly selected sample of medical wards in public hospitals between December 2006 and June 2007; all patients admitted during a 2-week period were included. An ADR-related hospitalization case was defined as a hospital admission because of an ADR, and an independent committee reviewed and validated all potential cases. Preventability was assessed using the French ADR preventability scale. Data were extrapolated to the population of France. Among 2692 admissions, 97 were related to an ADR (incidence 3.6%, 95% confidence interval, CI [2.8-4.4]). Patients admitted for an ADR were significantly older than those admitted for other reasons (P < 0.001). A third (32.0%) of ADR-related hospitalizations were 'preventable', 16.5% 'potentially preventable'. Drug interactions accounted for 29.9% of ADR-related hospitalizations. The most frequent causes of ADR-related hospitalizations were vascular disorders (20.6%), mainly bleeding complications, central nervous system disorders (11.3%), gastrointestinal disorders, and general disorders (9.3%). Antithrombotic and antineoplastic agents were the most frequently involved (12.6% each), followed by diuretics and analgesics (9.0% each). Vitamin-K-antagonists (VKAs) were the most common drugs associated with admission. The estimated annual number of ADR-related hospitalizations in France was 143 915 (95% CI [112 063-175 766]). ADRs were a significant cause of hospital admission in 2006-2007, in particular those due to VKAs. As new oral anticoagulants (NOACs) have been marketed, more attention needs to be paid to ensure a safe use of antithrombotic agents.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
CNRS
Inserm
Université de Lille

Collections :

Lille Neurosciences & Cognition (LilNCog) - U 1172

Équipe(s) de recherche :

Troubles cognitifs dégénératifs et vasculaires

Date de dépôt :

2019-11-27T13:02:34Z

Incidence of hospital admissions due to ... BibTeX CSV Excel RIS

Incidence of hospital admissions due to ...

BibTeX

CSV

Excel

RIS